243 related articles for article (PubMed ID: 2415776)
1. Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.
Shirahama T; Skinner M; Cohen AS; Gejyo F; Arakawa M; Suzuki M; Hirasawa Y
Lab Invest; 1985 Dec; 53(6):705-9. PubMed ID: 2415776
[TBL] [Abstract][Full Text] [Related]
2. Amyloid deposition in systemic organs in long-term hemodialysis patients.
Ogawa H; Saito A; Hirabayashi N; Hara K
Clin Nephrol; 1987 Oct; 28(4):199-204. PubMed ID: 3319310
[TBL] [Abstract][Full Text] [Related]
3. Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis.
Varga J; Idelson BA; Felson D; Skinner M; Cohen AS
Arch Intern Med; 1987 Aug; 147(8):1455-7. PubMed ID: 2443098
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.
Gejyo F; Odani S; Yamada T; Honma N; Saito H; Suzuki Y; Nakagawa Y; Kobayashi H; Maruyama Y; Hirasawa Y
Kidney Int; 1986 Sep; 30(3):385-90. PubMed ID: 3537446
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.
Gejyo F; Homma N; Suzuki Y; Arakawa M
N Engl J Med; 1986 Feb; 314(9):585-6. PubMed ID: 3080684
[No Abstract] [Full Text] [Related]
6. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
Argiles A; Mourad G; Axelrud-Cavadore C; Cavadore JC; Mion C
Nephrologie; 1987; 8(2):51-4. PubMed ID: 3302740
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunohistochemical findings in dialysis-related amyloidosis. An analysis of 16 cases.
Solé M; Cardesa A; Palacín A; Muñoz-Gómez J; Campistol JM
Appl Pathol; 1989; 7(6):350-60. PubMed ID: 2701266
[TBL] [Abstract][Full Text] [Related]
8. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
Saito A; Gejyo F
Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
[TBL] [Abstract][Full Text] [Related]
9. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
[TBL] [Abstract][Full Text] [Related]
10. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal involvement of dialysis-related amyloidosis.
Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
[TBL] [Abstract][Full Text] [Related]
12. Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome.
Ullian ME; Hammond WS; Alfrey AC; Schultz A; Molitoris BA
Medicine (Baltimore); 1989 Mar; 68(2):107-15. PubMed ID: 2646507
[TBL] [Abstract][Full Text] [Related]
13. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
[TBL] [Abstract][Full Text] [Related]
14. [Carpal tunnel syndrome, amyloid tenosynovitis and periodic hemodialysis].
Clanet M; Mansat M; Durroux R; Testut MF; Guiraud B; Rascol A; Conte J
Rev Neurol (Paris); 1981; 137(10):613-24. PubMed ID: 7323575
[TBL] [Abstract][Full Text] [Related]
15. [Mixed type amyloidomas, beta2 microglobulin and AL lambda, in a long term hemodialysis patient].
Menet E; Petit ML; Bridoux F; Touchard G; Duport G; Levillain P; Babin P
Nephrologie; 2001; 22(3):115-8. PubMed ID: 11436666
[TBL] [Abstract][Full Text] [Related]
16. [A histological study on the synovial tissue of rat knee joints in the experimental beta 2-microglobulin derived amyloidosis].
Ueda T
Ryumachi; 1992 Aug; 32(4):308-17. PubMed ID: 1411793
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
Hind CR; Tennent GA; Evans DJ; Pepys MB
J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study.
Bardin T; Zingraff J; Shirahama T; Noel LH; Droz D; Voisin MC; Drueke T; Dryll A; Skinner M; Cohen AS
Am J Med; 1987 Sep; 83(3):419-24. PubMed ID: 3310621
[TBL] [Abstract][Full Text] [Related]
19. Amyloid and non-amyloid carpal tunnel syndrome in patients receiving chronic renal dialysis.
Chary-Valckenaere I; Kessler M; Mainard D; Schertz L; Chanliau J; Champigneulle J; Pourel J; Gaucher A; Netter P
J Rheumatol; 1998 Jun; 25(6):1164-70. PubMed ID: 9632081
[TBL] [Abstract][Full Text] [Related]
20. Bilateral beta 2-microglobulin amyloidomas of the buttocks in a long-term hemodialysis patient.
Tom Y; Htwe M; Chandra R; Smith-Behn DJ
Arch Pathol Lab Med; 1994 Jun; 118(6):651-3. PubMed ID: 8204014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
